year
review
paper
first
seri
three
review
paper
highlight
relev
articl
publish
respirolog
respiratori
medicin
journal
acut
lung
injuri
interstiti
lung
diseas
ild
sleep
pulmonari
physiolog
unlik
tradit
ard
ard
featur
epitheli
endotheli
injuri
injur
epithelium
endothelium
orchestr
provok
massiv
inflamm
lung
lead
capillari
leakag
eventu
inhomogen
alveolar
alveolar
flood
process
fluid
leakag
activepass
transport
driven
ion
movement
hydrostat
pressur
cystic
fibrosi
transmembran
regul
conduct
shown
particip
alveolar
fluid
transport
capillari
compart
inhibit
chlorid
transport
worsen
lung
injuri
induc
lipopolysaccharid
rodent
model
suggest
inhibit
activ
fluid
transport
may
delay
lung
injuri
among
variou
risk
factor
bile
acid
aspir
induc
lung
injuri
kinas
phosphoryl
well
cytosol
phospholipas
product
result
attenu
junction
protein
occludin
zonula
similarli
pseudomona
lung
injuri
model
claudin
significantli
upregul
degre
bronchoalveolar
lavag
claudin
level
associ
lung
injuri
result
strongli
suggest
protect
lung
injuri
occur
junction
protein
express
alveolar
epithelium
enzym
ace
play
role
pathogenesi
ard
bronchoalveolar
lavag
sampl
ard
patient
show
increas
decreas
cleav
angiotensin
ii
form
angiotensin
cleav
angiotensin
form
angiotensin
ii
angiostatin
inhibitor
reduc
lung
injuri
mous
suggest
imbal
ace
express
ard
potenti
therapi
downregul
differ
manoeuvr
develop
quantifi
lung
oedema
extravascular
lung
water
guid
manag
recent
studi
use
comput
tomographi
imag
show
inhomogen
distribut
lung
injuri
ard
patient
level
inhomogen
associ
chest
ultrasound
appli
ard
quantifi
lung
oedema
subpleur
consolid
imag
techniqu
provid
addit
inform
lung
water
may
help
clinic
evalu
manag
fluid
administr
mechan
ventil
set
low
tidal
volum
mlkg
ventil
strategi
shown
reduc
mortal
ard
even
lower
tidal
volum
provid
addit
benefit
recent
studi
show
ventil
mlkg
combin
extracorpor
remov
significantli
increas
ventil
free
day
sever
hypox
prone
posit
ventil
shown
improv
surviv
sever
ard
although
protocol
might
applic
medic
regard
ventil
mode
adapt
support
ventil
equival
volum
control
ventil
mortal
patient
consist
previou
report
lung
eventu
heal
stem
cell
mobilizationrepopul
tissu
regener
exogen
stem
cell
extens
studi
differ
lung
injuri
anim
model
test
efficaci
administr
rout
underli
mechan
far
known
exogen
stem
cell
heal
lung
injuri
engraft
paracrin
secret
immun
modul
growth
factor
product
antibiot
peptid
synthesi
far
clinic
trial
assess
stem
cell
number
respiratori
condit
consid
target
stem
cell
treatment
includ
ard
chronic
progress
diseas
idiopath
pulmonari
fibrosi
ipf
chronic
obstruct
pulmonari
diseas
copd
outcom
trial
known
next
year
bronchiectasi
character
viciou
cycl
chronic
purul
airway
inflamm
bronchodil
neutrophil
play
import
role
airway
inflamm
activ
neutrophil
studi
idiopath
bronchiectasi
control
result
show
similar
respons
neutrophil
granulocyt
stimul
factor
two
group
suggest
neutrophil
phagocytosi
gener
oxid
speci
preserv
bronchiectasi
although
exhal
condens
may
detect
macrolid
antibiot
includ
azithromycin
shown
benefici
reduc
symptom
underli
mechan
thought
biofilm
disrupt
help
antibiot
penetr
suppress
activ
airway
inflamm
sarcoidosi
remain
enigmat
multifacet
condit
unknown
aetiolog
number
group
previous
report
neg
correl
activ
cigarett
smoke
develop
hattori
et
al
sought
assess
relationship
sarcoidosi
cigarett
smoke
contrast
studi
undertaken
found
strikingli
high
rate
smoke
sarcoid
patient
men
women
smoke
common
sarcoid
patient
control
almost
decil
age
apart
men
interestingli
hattori
colleagu
note
trend
toward
increas
parenchym
involv
sarcoid
patient
smoke
compar
never
data
thought
provok
need
caveat
fact
studi
retrospect
reli
smoke
preval
data
gener
japanes
popul
drawn
separ
conduct
research
suchankova
et
al
undertook
studi
myeloid
cell
isol
bronchoalveolar
lavag
patient
explor
express
pattern
trigger
receptor
express
myeloid
two
receptor
belong
immunoglobulin
superfamili
play
role
innat
immun
respons
infect
act
drive
cell
fusion
granuloma
format
trigger
receptor
express
myeloid
express
increas
cell
surfac
bronchoalveolar
lavag
cell
sarcoid
compar
bronchoalveolar
lavag
cell
isol
individu
form
ild
observ
support
role
infect
trigger
develop
sarcoid
also
suggest
trigger
receptor
express
myeloid
express
level
might
effect
biomark
discrimin
individu
ild
ild
caus
rare
orphan
lung
diseas
often
overlook
medic
literatur
yet
strike
treatment
advanc
last
decad
come
diseas
insight
deriv
rare
diseas
often
reveal
diseas
mechan
contribut
understand
common
disord
respirolog
publish
review
treatment
option
pulmonari
alveolar
paper
leth
et
al
explor
detail
current
understand
regard
role
granulocyt
stimul
factor
autoantibodi
key
pathogenet
mechan
major
individu
pulmonari
alveolar
proteinosi
complementari
role
play
novel
therapeut
whole
lung
lavag
disord
increasingli
recogn
last
year
immunoglobulin
diseas
condit
character
rais
serum
multiorgan
deposit
plasma
cell
associ
fibrosi
good
therapeut
respons
corticosteroid
becom
increasingli
clear
result
number
specif
pulmonari
abnorm
matsui
et
al
provid
excel
overview
constel
lung
manifest
larg
case
seri
individu
lung
frequent
observ
find
mediastin
adenopathi
thicken
perilymphat
interstitium
intralobular
septa
proport
case
subpleur
peribronchovascular
consolid
appar
lymphat
spread
diseas
resembl
appear
pulmonari
lymphoprolif
diseas
author
emphas
import
obtain
histolog
confirm
suspect
case
lung
diseas
oblit
bronchiol
extrem
debilit
condit
associ
wide
rang
underli
factor
includ
transplant
reject
autoimmun
diseas
viral
infect
occup
mechan
divers
condit
lead
develop
oblit
bronchiol
remain
unknown
hashimoto
et
al
sought
understand
environment
exposur
sauropu
androgyn
veget
commonli
eaten
thailand
result
individu
develop
oblit
aqueou
fraction
sauropu
androgyn
extract
trigger
cytokin
releas
monocyt
releas
cytokin
tumour
necrosi
increas
sauropu
androgyn
extract
monocyt
healthi
control
increas
even
monocyt
deriv
individu
oblit
bronchiol
observ
suggest
host
environment
factor
import
develop
oblit
bronchiol
autotitr
cpap
devic
avail
determin
effect
therapeut
pressur
fix
cpap
ongo
home
manag
patient
osa
year
howev
concern
earlier
work
differ
algorithm
use
variou
manufactur
may
affect
efficaci
devic
control
apnoea
damiani
colleagu
evalu
effect
two
autotitr
cpap
devic
driven
differ
algorithm
determin
therapeut
pressur
fix
devic
test
author
gave
similar
pressur
recommend
well
provid
signific
similar
improv
sleep
breath
one
purport
advantag
autotitr
cpap
lower
mean
overnight
pressur
may
deliv
patient
benefici
term
pressur
toler
howev
luo
colleagu
found
chines
popul
pressur
deriv
consist
greater
determin
manual
identifi
author
may
reflect
greater
sensit
flow
sensor
within
autotitr
cpap
devic
detect
respond
flow
limit
compar
thermistor
use
manual
titrat
studi
damiani
et
al
highlight
need
studi
evalu
whether
clinic
import
outcom
differ
exist
differ
devic
approach
although
highli
efficaci
cpap
therapi
toler
accept
treatment
signific
number
patient
osa
mind
anandam
et
al
undertook
larg
observ
studi
patient
sever
osa
index
follow
median
period
patient
initi
receiv
cpap
although
continu
therapi
studi
period
anoth
patient
switch
mandibular
advanc
splint
ma
declin
intervent
control
group
individu
index
follow
time
period
cumul
cardiovascular
mortal
group
similar
control
group
mortal
three
group
significantli
lower
untreat
sever
osa
group
howev
differ
mortal
patient
treat
cpap
ma
seen
even
though
patient
treat
ma
higher
residu
index
compar
individu
vs
p
observ
result
studi
consist
find
recent
random
trial
compar
ma
cpap
therapi
patient
full
spectrum
osa
anandam
health
outcom
similar
despit
residu
event
higher
group
discuss
editori
similar
outcom
two
therapi
like
aris
higher
complianc
ma
offset
lower
efficaci
date
major
limit
ma
inabl
object
monitor
complianc
howev
chang
recent
develop
microsensor
technolog
permit
chip
embed
within
devic
enabl
accur
usag
although
osa
common
find
major
patient
obes
hypoventil
syndrom
cpap
univers
success
improv
breath
popul
salord
et
al
provid
use
clinic
insight
resolut
breath
patient
oh
factor
could
use
predict
like
fail
cpap
lower
overnight
oxygen
satur
optim
cpap
first
treatment
higher
partial
arteri
carbon
dioxid
concentr
month
use
measur
detect
poor
respond
follow
month
therapi
interest
find
studi
progress
improv
paramet
studi
period
confirm
result
earlier
random
studi
show
initi
incomplet
respond
cpap
may
improv
respirolog
publish
two
excel
review
area
sleep
breath
first
roux
discuss
relationship
restless
leg
syndrom
breath
provid
comprehens
overview
effect
treat
restless
leg
osa
vice
paper
yamanaka
sadikot
outlin
impact
opioid
use
highlight
widespread
effect
drug
respiratori
system
breath
includ
immun
cell
function
airway
reactiv
pulmonari
increas
use
opioid
commun
review
time
remind
drug
beyond
caus
respiratori
system
depress
final
wang
colleagu
use
mous
model
demonstr
differenti
effect
hypercapnia
synthesi
neuropeptid
involv
regul
sleep
part
investig
osa
focus
hypoxia
futur
studi
examin
role
peptid
respons
hypercapnia
human
may
shed
light
pathogenesi
osa
ultrasonographi
start
use
extens
assess
respiratori
muscl
function
especi
critic
care
soilemezi
et
util
ultrasonographi
assess
diaphragm
kinet
healthi
volunt
without
addit
acut
inspiratori
resist
load
addit
inspiratori
resist
decreas
respiratori
rate
increas
tidal
volum
associ
reduct
veloc
diaphragmat
contract
diaphragmat
excurs
chang
observ
mouthpiec
nose
clip
author
suggest
distinguish
chang
diaphragm
motion
inspiratori
load
may
make
diaphragm
ultrasonographi
use
condit
upper
airway
consider
bodi
literatur
look
specif
train
respiratori
muscl
tri
improv
function
statu
athlet
perform
varieti
recent
illi
et
al
conclud
respiratori
muscl
train
improv
endur
exercis
perform
healthi
individu
greater
improv
less
fit
subject
sport
longer
compar
effect
week
respiratori
muscl
train
versu
placebo
breath
vs
maxim
inspiratori
effort
respect
report
chang
lung
function
peak
oxygen
consumpt
either
group
howev
time
volit
exhaust
increment
treadmil
test
veloc
peak
oxygen
consumpt
increas
respiratori
muscl
train
postul
author
perform
improv
may
due
reduc
effort
percept
follow
respiratori
muscl
train
allow
subject
toler
higher
intens
exercis
caus
pulmonari
arteri
hypertens
poorli
understood
condit
associ
vascular
remodel
due
excess
cell
prolifer
reduc
rate
improv
understand
patholog
pah
may
improv
earli
diagnosi
lead
better
treatment
devast
diseas
two
studi
respirolog
made
signific
contribut
understand
pathophysiolog
complex
condit
kabata
et
report
preval
mutat
gene
bone
morphogenet
protein
receptor
type
receptor
associ
abnorm
prolifer
pulmonari
vascular
smooth
muscl
cell
endotheli
cell
dysfunct
similar
japanes
patient
pah
compar
report
popul
furthermor
surviv
pah
unaffect
mutat
contrast
edward
et
investig
chang
peripher
lymphocyt
patient
idiopath
pah
connect
tissu
diseas
associ
ph
compar
healthi
control
correl
chang
transplant
free
surviv
studi
demonstr
defici
level
cytotox
natur
killer
cell
patient
pah
associ
increas
risk
death
author
suggest
larger
studi
need
investig
phenotyp
cell
differ
diseas
sever
explor
potenti
number
valid
instrument
avail
assess
health
statu
predict
mortal
guid
health
care
patient
respiratori
two
recent
addit
group
measur
tool
copd
assess
measur
health
statu
simplifi
acut
physiolog
score
develop
predict
mortal
critic
ill
two
origin
studi
respirolog
year
kon
report
copd
assess
test
respons
pulmonari
rehabilit
respiratori
diseas
patient
without
copd
correl
differ
domain
valid
chronic
respiratori
diseas
support
practic
altern
tradit
measur
contrast
lim
et
demonstr
gener
australasia
simplifi
acut
physiolog
score
show
poor
calibr
defin
agreement
individu
probabl
actual
prognosi
outcom
korean
intens
care
unit
patient
howev
util
data
initi
develop
cohort
custom
questionnair
show
good
discrimin
calibr
clearli
demonstr
predict
model
need
custom
use
within
differ
region
patient
respiratori
diseas
risk
hypoxaemia
especi
period
increas
metabol
demand
exercis
consider
need
accur
measur
arteri
oxyhaemoglobin
satur
wilson
compar
simultan
oxyhaemoglobin
satur
use
puls
oximetri
measur
forehead
finger
patient
copd
desatur
exercis
valu
compar
arteri
capillari
sampl
measur
treadmil
walk
author
demonstr
compar
arteri
sampl
lower
higher
finger
forehead
oximetri
respect
author
correctli
state
arteri
capillari
blood
commonli
slightli
lower
oxygen
arteri
suggest
forehead
measur
like
accur
howev
arteri
sampl
measur
definit
answer
ascertain
nevertheless
data
import
suggest
consider
need
standard
sensor
type
comparison
centr
patient
accur
number
potenti
way
predict
extent
hypoxaemia
patient
may
experi
air
gold
standard
current
hypox
inhal
test
hit
expos
patient
similar
inspir
fraction
oxygen
experienc
regular
aircraft
cabin
howev
hit
avail
special
pulmonari
function
test
laboratori
readili
avail
mani
patient
respiratori
diseas
would
like
travel
ling
et
assess
whether
oxyhaemoglobin
satur
hit
associ
measur
rest
follow
min
step
exercis
vital
capac
andor
dlco
patient
respiratori
diseas
exercis
correl
hit
report
better
predictor
hit
rest
spirometr
lung
function
variabl
dlco
util
multipl
linear
regress
ling
et
present
equat
incorpor
forc
vital
capac
well
rest
could
use
predict
hit
special
test
avail
